Ruxolitinib in Estrogen Receptor Positive Breast Cancer
Clinical trial NCT01594216 · COMPLETED
Trial details
- NCT number
- NCT01594216
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2016-04-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.